ILiAD Biotechnologies
Latest round
- Series B
Last raised
- Feb 2026
Total raised
- $115M
Investors
- 4
About ILiAD Biotechnologies
Based in Florida, US, and founded in 2012, ILiAD Biotechnologies, LLC operates as a clinical-stage biotechnology company that develops vaccines to eradicate infectious diseases. ILiAD Biotechnologies, LLC offers a B-Tech vector platform that has developed BPZE1, a live attenuated pertussis vaccine that contains genetic modifications to eliminate, attenuate or inactivate three different B. pertussis toxins. It induces both mucosal and systemic immune responses, with the potential and immunity compared to the current intramuscular injection of purified pertussis antigens such as aPV.
Who invested in ILiAD Biotechnologies
4 investors across 1 round
See all investors in ILiAD Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Feb 10, 2026
Amount
$115M
Investors
Questions about ILiAD Biotechnologies
Who invested in ILiAD Biotechnologies?
ILiAD Biotechnologies has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ILiAD Biotechnologies raised?
ILiAD Biotechnologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ILiAD Biotechnologies last raise money?
ILiAD Biotechnologies's most recent round on record is a Series B, in Feb 2026.
What does ILiAD Biotechnologies do?
Based in Florida, US, and founded in 2012, ILiAD Biotechnologies, LLC operates as a clinical-stage biotechnology company that develops vaccines to eradicate infectious diseases.
Where is ILiAD Biotechnologies headquartered?
ILiAD Biotechnologies is headquartered in US.
Which VCs invest in companies like ILiAD Biotechnologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ILiAD Biotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ILiAD Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.